Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data analysis
PubMed 27057292 · doi:10.14797/mdcj-11-4-228
What was done
This is a narrative review summarizing the epidemiologic links, structural and pathophysiological mechanisms (specifically atrial remodeling and the renin-angiotensin-aldosterone system), and treatment parallels between hypertension and atrial fibrillation.
What was found
The authors report that hypertension is the most commonly encountered risk factor for incident atrial fibrillation, associated with a 1.8-fold increase in the risk of new-onset atrial fibrillation and a 1.5-fold increase in the risk of progression to permanent atrial fibrillation. No primary study data or confidence intervals are reported in the abstract.
Why it matters
Hypertension is a major modifiable risk factor, and understanding shared pathophysiological mechanisms underscores the role of guideline-directed antihypertensive therapy in potentially reducing atrial fibrillation incidence.
Limits
As a narrative review, it lacks a systematic search methodology or meta-analytic pooling. Specific source populations, sample sizes, effect bounds, and quantitative intervention outcomes are not reported in the abstract.
Cited by
- supports Atrial fibrillation is the most common cardiac dysrhythmia.